
According to a Federal Trade Commission (FTC) press release, Mark Seidman has been named as the Acting Assistant Director for the Mergers IV Division. Mark has served as Deputy Assistant Director for Mergers IV for the past six years. Prior to becoming Deputy Assistant Director, Mark served as Counsel to the Director under former Bureau Directors Debbie Feinstein and Rich Feinstein. Mark joined the Commission in 2005 as an attorney in the Mergers I Division, after graduating from George Washington Law School. During his time with the Commission, Mark also served on a detail to the US Attorney’s Office for the District of Columbia.
Steve Mohr has been named as Acting Deputy Assistant Director for the Mergers I Division. Steve previously served as a Counsel to the Director. Prior to joining the Front Office, Steve was an attorney in Mergers I where he was the co-lead trial counsel in the Bureau’s successful challenge to Otto Bock’s acquisition of Freedom. Steve received the Commission’s Louis D. Brandeis Award in 2015, which recognizes outstanding litigators at the Commission.
Emily Bowne has been named as Acting Deputy Assistant Director for the Mergers IV Division. Emily previously served as a Counsel to the Director. Prior to joining the Front Office, Emily was an attorney in Mergers IV. She has served on trial teams for the Commission’s successful challenges in Sanford/Mid Dakota and Advocate/NorthShore. Emily received the Commission’s Stephen Nye Award in 2016, which recognizes an attorney whose overall work performance far exceeds what is usually expected of a relatively new legal practitioner.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas